ServiceLiverpool, United KingdomFounded 2013· One of 2028 Service companies tracked by AMPulse
Personalized surgery technology company providing FDA-cleared digital platform for surgical planning and patient-specific medical devices
CEO / Founder
Henry Pinchbeck
Team Size
11-50
Stage
Active
Total Funding
$4.54M
Latest Round
Series A
Key Investors
Nodenza Venture Partners (led $2.5M Series A), Fenwall Investments (led previous £500K Series A and £1.2M Growth rounds)
Technology & Products
Key Products
FDA-cleared EmbedMed digital platform for surgical planning, patient-specific surgical guides and models, orthopedic and CMF solutions, cleanroom manufacturing facilities
Technological Advantage
Hospital-embedded facilities, ISO certified, CMF surgery expertise, FDA clearance
Differentiation
Value Proposition
Embedded 3D printing hubs in hospitals for personalized surgery solutions
Materialise, Stratasys Medical, 3D Systems Healthcare
Growth & Milestones
Growth Metrics
{"hospital_poc_sites": ["Alder Hey Liverpool", "Nuffield Oxford", "Wrightington", "Manchester Science Park CoE", "Texas Medical Center Houston", "Children's Nebraska Omaha"], "team_size_band": "11-50", "funding_raised": "$2.5M Series A (2025) + prior UK rounds (~$4.5M disclosed)", "expansion_markets": "UK, USA", "turnaround": "~10 working days image-to-sterile-guide"}
Major Milestones
2013: Founded in Kenya as social enterprise; 2018 £500K / 2020 £1.2M Fenwall rounds; 2023 rebrand to Insight Surgery + FDA 510(k) clearances; US cleanroom at Texas Medical Center; Apr 2025 $2.5M Series A (Nodenza); Nov 2025 Children's Nebraska partnership (Omaha manufacturing); Feb 2026 Manchester Science Park Centre of Excellence; manufacturing also Oxford/Houston/Omaha
Notable Customers
NHS hospitals (Alder Hey, Nuffield Oxford, Wrightington), Children's Nebraska, Hospital for Special Surgery (NY), University Hospitals Chicago, University of Florida Health, UAB Birmingham, Johns Hopkins (clinical users), academic medical centers and private hospitals in US/UK
Insight Surgery, formerly 3D LifePrints, operates a cross-Atlantic model that embeds additive manufacturing facilities directly within hospital systems. Its FDA-cleared EmbedMed platform digitizes the surgical planning workflow, enabling surgeons to order patient-specific guides, models, and devices produced on-site. This approach reduces lead times compared to centralized medical 3D printing services and integrates more closely with clinical workflows.
The company uses metal LPBF and polymer AM to manufacture surgical guides, anatomical models, and orthopedic and cranio-maxillofacial solutions. Its cleanroom facilities support ISO-certified production. Current hospital hubs include Alder Hey Children's Hospital in Liverpool, Nuffield Orthopaedic Centre in Oxford, and Wrightington Hospital, with expansion planned to London, Birmingham, Manchester, and Leeds. In the US, Insight Surgery has established a manufacturing presence at the Texas Medical Center.
Target customers include NHS hospitals, private healthcare systems, and research institutions. The company also supplies training aids to the United Nations humanitarian sector. Competitors include Materialise, Stratasys Medical, and 3D Systems Healthcare, but Insight Surgery differentiates through its on-site hub model and integrated digital platform, which covers the full workflow from imaging to device delivery.
Founded in 2013 as a social enterprise in Kenya, Insight Surgery has raised approximately $4.54M from investors including Nodenza Venture Partners and Fenwall Investments. Its leadership includes former NASA astronaut expertise. The key strategic question is whether the hospital-embedded hub model can scale beyond a handful of sites while maintaining FDA clearance and cost efficiency against centralized medical AM providers.